Newton Biocapital's approach is to support promising startup projects as well as neglected or undervalued late-stage life sciences companies in the "core of Europe" and Japan. We invest in therapeutic, diagnostic, medical device, clinical nutrition and digital biotech companies that share our…
Employees: 11-50
Investment Type: Venture Capital
Investment Stage: Series B; Series C; Series D; Series E; Series F; Series G; Series H
Portfolio 13
| Date | Name | Website | Total Raised | Location |
| 08.06.2023 | Santero Th... | santero.be | $8.57M | - |
| 15.10.2018 | Sequana Me... | sequanamed... | $55.46M | Belgium, E... |
| - | Perseus Pr... | ppmx.com | - | - |
| - | Dim3 | dim3.com | - | Belgium, L... |
| - | ABOLERIS P... | aboleris-p... | - | France, Pa... |
| - | EPICS THER... | epicsthera... | - | Belgium, H... |
| - | DeuterOnco... | deuteronco... | $6.12M | - |
| - | J-Pharma | j-pharma.c... | - | Japan, Oku... |
| - | ChromaCure | chromacure... | - | - |
| - | NEUVASQ BI... | neuvasq.co... | - | Belgium, H... |
Show more
Mentions in press and media 1
| Date | Title | Description | Source |
| 15.10.2018 | Sequana Medical establishes new corporate headquarters in Gh... | Ghent, Belgium: 15 October 2018 – Sequana Medical NV, a commercial stage medical device company focu... | capricorn.... |